Pharmacokinetics, safety, and tolerability of BMS‐986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment
Qosa, Hisham, de Oliveira, Claudia H. M. C., Cizza, Giovanni, Lawitz, Eric J., Colletti, Nicholas, Wetherington, Jeffrey, Charles, Edgar D., Tirucherai, Giridhar S.
Published in Clinical and translational science (01.10.2023)
Published in Clinical and translational science (01.10.2023)
Get full text
Journal Article
Pegbelfermin (BMS‐986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study
Charles, Edgar D., Neuschwander‐Tetri, Brent A., Pablo Frias, Juan, Kundu, Sudeep, Luo, Yi, Tirucherai, Giridhar S., Christian, Rose
Published in Obesity (Silver Spring, Md.) (01.01.2019)
Published in Obesity (Silver Spring, Md.) (01.01.2019)
Get full text
Journal Article
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
Boxer, Adam L, Qureshi, Irfan, Ahlijanian, Michael, Grundman, Michael, Golbe, Lawrence I, Litvan, Irene, Honig, Lawrence S, Tuite, Paul, McFarland, Nikolaus R, O'Suilleabhain, Padraig, Xie, Tao, Tirucherai, Giridhar S, Bechtold, Clifford, Bordelon, Yvette, Geldmacher, David S, Grossman, Murray, Isaacson, Stuart, Zesiewicz, Theresa, Olsson, Tina, Muralidharan, Kumar Kandadi, Graham, Danielle L, O'Gorman, John, Haeberlein, Samantha Budd, Dam, Tien
Published in Lancet neurology (01.06.2019)
Published in Lancet neurology (01.06.2019)
Get full text
Journal Article
BMS‐986263 in patients with advanced hepatic fibrosis: 36‐week results from a randomized, placebo‐controlled phase 2 trial
Lawitz, Eric J., Shevell, Diane E., Tirucherai, Giridhar S., Du, Shuyan, Chen, Warner, Kavita, Uma, Coste, Angie, Poordad, Fred, Karsdal, Morten, Nielsen, Mette, Goodman, Zachary, Charles, Edgar D.
Published in Hepatology (Baltimore, Md.) (01.04.2022)
Published in Hepatology (Baltimore, Md.) (01.04.2022)
Get full text
Journal Article
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study
Loomba, Rohit, Sanyal, Arun J., Nakajima, Atsushi, Neuschwander-Tetri, Brent A., Goodman, Zachary D., Harrison, Stephen A., Lawitz, Eric J., Gunn, Nadege, Imajo, Kento, Ravendhran, Natarajan, Akahane, Takemi, Boone, Bradly, Yamaguchi, Masayuki, Chatterjee, Arkendu, Tirucherai, Giridhar S., Shevell, Diane E., Du, Shuyan, Charles, Edgar D., Abdelmalek, Manal F.
Published in Clinical gastroenterology and hepatology (01.01.2024)
Published in Clinical gastroenterology and hepatology (01.01.2024)
Get full text
Journal Article
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study
Abdelmalek, Manal F., Sanyal, Arun J., Nakajima, Atsushi, Neuschwander-Tetri, Brent A., Goodman, Zachary D., Lawitz, Eric J., Harrison, Stephen A., Jacobson, Ira M., Imajo, Kento, Gunn, Nadege, Halegoua-DeMarzio, Dina, Akahane, Takemi, Boone, Bradly, Yamaguchi, Masayuki, Chatterjee, Arkendu, Tirucherai, Giridhar S., Shevell, Diane E., Du, Shuyan, Charles, Edgar D., Loomba, Rohit
Published in Clinical gastroenterology and hepatology (01.01.2024)
Published in Clinical gastroenterology and hepatology (01.01.2024)
Get full text
Journal Article
MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity
Cheng, Dong, Zinker, Bradley A., Luo, Yi, Shipkova, Petia, De Oliveira, Claudia H., Krishna, Gopal, Brown, Elizabeth A., Boehm, Stephanie L., Tirucherai, Giridhar S., Gu, Huidong, Ma, Zhengping, Chu, Ching-Hsuen, Onorato, Joelle M., Kopcho, Lisa M., Ammar, Ron, Smith, Julia, Devasthale, Pratik, Lawrence, R. Michael, Stryker, Steven A., Dierks, Elizabeth A., Azzara, Anthony V., Carayannopoulos, Leon, Charles, Edgar D., Lentz, Kimberley A., Gordon, David A.
Published in Cell metabolism (01.11.2022)
Published in Cell metabolism (01.11.2022)
Get full text
Journal Article
The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis
Abdelmalek, Manal F., Charles, Edgar D., Sanyal, Arun J., Harrison, Stephen A., Neuschwander-Tetri, Brent A., Goodman, Zachary, Ehman, Richard A., Karsdal, Morten, Nakajima, Atsushi, Du, Shuyan, Tirucherai, Giridhar S., Klinger, George H., Mora, Johanna, Yamaguchi, Masayuki, Shevell, Diane E., Loomba, Rohit
Published in Contemporary clinical trials (01.05.2021)
Published in Contemporary clinical trials (01.05.2021)
Get full text
Journal Article
Evaluating a Multiscale Mechanistic Model of the Immune System to Predict Human Immunogenicity for a Biotherapeutic in Phase 1
Hamuro, Lora, Tirucherai, Giridhar S., Crawford, Sean M., Nayeem, Akbar, Pillutla, Renuka C., DeSilva, Binodh S., Leil, Tarek A., Thalhauser, Craig J.
Published in The AAPS journal (01.09.2019)
Published in The AAPS journal (01.09.2019)
Get full text
Journal Article
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)
Corte, Tamera J, Lancaster, Lisa, Swigris, Jeffrey J, Maher, Toby M, Goldin, Jonathan G, Palmer, Scott M, Suda, Takafumi, Ogura, Takashi, Minnich, Anne, Zhan, Xiaojiang, Tirucherai, Giridhar S, Elpers, Brandon, Xiao, Hong, Watanabe, Hideaki, Smith, R Adam, Charles, Edgar D, Fischer, Aryeh
Published in BMJ open respiratory research (01.12.2021)
Published in BMJ open respiratory research (01.12.2021)
Get full text
Journal Article
Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis
Luo, Yi, Decato, Benjamin E., Charles, Edgar D., Shevell, Diane E., McNaney, Colleen, Shipkova, Petia, Apfel, Abraham, Tirucherai, Giridhar S., Sanyal, Arun J.
Published in JHEP reports (01.01.2022)
Published in JHEP reports (01.01.2022)
Get full text
Journal Article
타우병증 치료를 위한 조성물 및 방법
BURTON LORI S, QUAN YONG, BURGESS MICHAEL FRANS, HUANG MASANO TLANECI, TIRUCHERAI GIRIDHAR S
Year of Publication 19.02.2020
Get full text
Year of Publication 19.02.2020
Patent
LPA1 ANTAGONISTS FOR TREATING INTERSTITIAL LUNG DISEASE
TIRUCHERAI, Giridhar S, FISCHER, Aryeh, TAO, Shiwei, CHARLES, Edgar D
Year of Publication 04.07.2024
Get full text
Year of Publication 04.07.2024
Patent